OptionsHouse

Options Trading News

April 19, 2013  Fri 7:34 AM CT

VRTX: SEE CHART GET CHAIN FIND STRATEGIES
Improved Lung Function Cited

Vertex Pharmaceuticals said its VX-661 compound improved breathing for patients suffering from cystic fibrosis. The Phase II study combined the drug with another one of the company's products that is already in the market. VRTX rockets 61 percent before the bell on my tradeMONSTER platform.

Dell Lower as Blackstone Backs Out

Dell had surged on takeover chatter, but now Blackstone Group is backing out. The private-equity firm cited the recent plunge in PC sales as the reason. DELL falls almost 3 percent in early trading.

Air Methods Expects Surprise Loss

Air Methods said it expects to report a first-quarter loss of $0.14 to $0.16 a share. Analysts, however, had expected profit of $0.32 a share from the medical-transport company. AIRM drops 17 percent in the premarket.
Share this article with your friends


Related Stories

VRTX

Vertex draws upside bet before earnings

January 26, 2016

A February call spread is bullish on the drug developer, which announces quarterly results after the market closes tomorrow.

OptionsHouse

TRADING WEEKLY OPTIONS

The fastest money in the market
View full report »

Premium Services

Upcoming Webinar:

How to Defend Your Portfolio and Profit in a Market Selloff

http://bit.ly/1OSMWU6

Jon Najarian and Sandy Chaikin of Chaikin Analytics demonstrate how to play defense when the market is selling off. And, how to turn misery into money, whether investing in stocks or trading options.

Education & Strategy

The sweet spot

When using the Stock Replacement Strategy, we must remember that in reality, we are doing a STOCK trade. We are just using options. We are replacing the stock position with an option position (long calls).

View more education articles »